Highly-awaited PhIII study of Gates-backed tuberculosis vaccine underway

A large study of an experimental vaccine for the world’s biggest infectious disease has finally kicked off in South Africa.

The Bill & Melinda Gates Medical Research Institute (MRI) will test a tuberculosis vaccine’s ability to prevent latent infections from causing potentially deadly lung disease. Last summer Wellcome said it would chip in $150 million for the study and the Gates Foundation said it would foot the remaining $400 million of the estimated $550 million cost of running the 20,000-person Phase III trial.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Major study links loneliness to increased risk of dementia

New research led by Florida State University College of Medicine faculty quantified the association between loneliness and dementia by analyzing data from more than 600,000

October 22, 2024

Sodium Channel Blocker Relieves Acute Pain in Phase III Data

PHILADELPHIA — An oral, non-addictive sodium channel blocker safely relieved moderate-to-severe acute pain following surgery, according to phase III data that could support regulatory approval.

October 23, 2024

Study reveals how to customize artificial tears to alleviate dry eye symptoms

Compared to artificial tears, or eye drops, human tears are significantly more complex liquids, with a wide range of components including lipids, carbohydrates, proteins, water,

July 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.